Obesity and loss of disease-free years owing to major non-communicable diseases: a multicohort study

Abstract

SummaryBackgroundObesity increases the risk of several chronic diseases, but the extent to which the obesity-related loss of disease-free years varies by lifestyle category and across socioeconomic groups is unclear. We estimated the number of years free from major non-communicable diseases in adults who are overweight and obese, compared with those who are normal weight.MethodsWe pooled individual-level data on body-mass index (BMI) and non-communicable diseases from men and women with no initial evidence of these diseases in European cohort studies from the Individual-Participant-Data Meta-Analysis in Working Populations consortium. BMI was assessed at baseline (1991–2008) and non-communicable diseases (incident type 2 diabetes, coronary heart disease, stroke, cancer, asthma, and chronic obstructive pulmonary disease) were ascertained via linkage to records from national health registries, repeated medical examinations, or self-report. Disease-free years from age 40 years to 75 years associated with underweight (BMI <18·5 kg/m2), overweight (≥25 kg/m2 to <30 kg/m2), and obesity (class I [mild] ≥30 kg/m2 to <35 kg/m2; class II–III [severe] ≥35 kg/m2) compared with normal weight (≥18·5 kg/m2 to <25 kg/m2) were estimated.FindingsOf 137 503 participants from ten studies, we excluded 6973 owing to missing data and 10 349 with prevalent disease at baseline, resulting in an analytic sample of 120 181 participants. Of 47 127 men, 211 (0·4%) were underweight, 21 468 (45·6%) normal weight, 20 738 (44·0%) overweight, 3982 (8·4%) class I obese, and 728 (1·5%) class II–III obese. The corresponding numbers among the 73 054 women were 1493 (2·0%), 44 760 (61·3%), 19 553 (26·8%), 5670 (7·8%), and 1578 (2·2%), respectively. During 1 328 873 person-years at risk (mean follow-up 11·5 years [range 6·3–18·6]), 8159 men and 8100 women developed at least one non-communicable disease. Between 40 years and 75 years, the estimated number of disease-free years was 29·3 (95% CI 28·8–29·8) in normal-weight men and 29·4 (28·7–30·0) in normal-weight women. Compared with normal weight, the loss of disease-free years in men was 1·8 (95% CI −1·3 to 4·9) for underweight, 1·1 (0·7 to 1·5) for overweight, 3·9 (2·9 to 4·9) for class I obese, and 8·5 (7·1 to 9·8) for class II–III obese. The corresponding estimates for women were 0·0 (−1·4 to 1·4) for underweight, 1·1 (0·6 to 1·5) for overweight, 2·7 (1·5 to 3·9) for class I obese, and 7·3 (6·1 to 8·6) for class II–III obese. The loss of disease-free years associated with class II–III obesity varied between 7·1 and 10·0 years in subgroups of participants of different socioeconomic level, physical activity level, and smoking habit.InterpretationMild obesity was associated with the loss of one in ten, and severe obesity the loss of one in four potential disease-free years during middle and later adulthood. This increasing loss of disease-free years as obesity becomes more severe occurred in both sexes, among smokers and non-smokers, the physically active and inactive, and across the socioeconomic hiera...

Very low‐energy and low‐energy formula diets: Effects on weight loss, obesity co‐morbidities and type 2 diabetes remission – an update on the evidence for their use in clinical practice

“…Obesity can contribute to a greater risk of non‐communicable diseases (NCDs) including type 2 diabetes (T2D), ischaemic heart disease, stroke and some cancers (Nyberg et al . ). With 71% of worldwide deaths attributed to NCDs (World Health Organization ), effective treatment and management strategies for obesity and its co‐morbidities, specifically T2D, are key priorities for healthcare systems worldwide.…”

“…In 2016, it was estimated that globally, 1.9 billion adults were overweight and 650 million were obese (World Health Organization 2018b), representing an overall prevalence of approximately 12% (Afshin et al 2017). Obesity can contribute to a greater risk of non-communicable diseases (NCDs) including type 2 diabetes (T2D), ischaemic heart disease, stroke and some cancers (Nyberg et al 2018). With 71% of worldwide deaths attributed to NCDs (World Health Organization 2018a), effective treatment and management strategies for obesity and its co-morbidities, specifically T2D, are key priorities for healthcare systems worldwide.…”

Cracking the combination: Gut hormones for the treatment of obesity and diabetes

“…These numbers correspond respectively to 39% and 13% of the adult population . Obesity drives the pathogenesis of other diseases such as type 2 diabetes, cardiovascular disease, related musculoskeletal disorders such as osteoarthritis and some cancers (endometrial, breast, ovarian, prostate, liver, gallbladder, kidney and colon) . Obesity is therefore responsible for a great deal of mortality throughout the world .…”

“…1 Obesity drives the pathogenesis of other diseases such as type 2 diabetes, cardiovascular disease, related musculoskeletal disorders such as osteoarthritis and some cancers (endometrial, breast, ovarian, prostate, liver, gallbladder, kidney and colon). 2 Obesity is therefore responsible for a great deal of mortality throughout the world. 3 The aetiology of obesity lies fundamentally in an imbalance of energy homeostasis from the interaction of three factors: (a) increased energy intake through the supply of unlimited quantities of energy dense food and drink which are tuned to appeal to our appetites; (b) decreased energy expenditure as result of modern lifestyles (a more sedentary environment, contemporary modes of transportation, urbanization, reduction in sleep quality); (c) genetic and ethnic predispositions to obesity.…”

Identifying a human rights–based approach to obesity for States and civil society

“…The global obesity pandemic and its comorbidities, including diabetes mellitus, cardiovascular disease, cancer, osteoarthritis, and hypertension, pose risks to the life and health of individuals, the well‐being of families, and economic development . The risk factors for obesity arise at the level of genes, behaviours, and the environment.…”